SHS Acquires 24.9% Minority Stake in Blazejewski MEDI-TECH GmbH

Erbe Group Acquires Blazejewski MEDI-TECH GmbH from SHS

October 28, 2022

Medical Devices

The Erbe Group has acquired the shares held by healthcare investor SHS in Blazejewski MEDI-TECH GmbH, a Baden-based OEM developer and manufacturer of 2D and 3D chip-on-the-tip endoscopes. SHS had held a minority stake since 2020 and supported the company's international expansion and product development; Erbe expects to combine its electrosurgery expertise with Blazejewski's endoscopy technologies to drive integrated "see and treat" solutions and further growth.

SHS Capital Acquires Majority Stake in Medizintechnik Rostock (MTR)

November 26, 2024

Medical Devices

Tübingen-based private equity firm SHS Capital has acquired a majority stake in German home care provider Medizintechnik Rostock GmbH (MTR) from the company’s two shareholder-managing directors, who remain significant shareholders. The investment will support MTR’s continued growth and nationwide expansion of its rental-based medical device and in-home service offerings across movement, electro and compression therapy.

SHS Capital Invests €18M in MESI Medical

June 22, 2023

Medical Devices

Tübingen-based healthcare investor SHS (SHS Gesellschaft für Beteiligungsmanagement mbH) has invested €18 million in MESI, a Slovenian medtech company that develops the MESI mTABLET digital diagnostic platform. The growth capital will be used to expand MESI’s sales organization and product portfolio — including AI-powered predictive applications — to accelerate adoption across primary care, assisted care and other healthcare settings.

SHS Invests in Blue Ocean Spine GmbH

January 12, 2021

Medical Devices

SHS Gesellschaft für Beteiligungsmanagement (SHS) is the lead investor in Blue Ocean Spine GmbH, a Tuttlingen, Germany-based developer of functional spinal implants that uses additive manufacturing. The investment will support product development, manufacturing scale-up and regulatory activities as Blue Ocean Spine advances next-generation expandable and anchor-equipped cage implants and targets future U.S. FDA approval.

Löwenstein Medical Acquires medigroba from SHS

April 22, 2021

Healthcare Services

Löwenstein Medical GmbH & Co. KG (Löwenstein Group) has acquired Balingen-based homecare specialist medigroba GmbH from healthcare investor SHS Gesellschaft für Beteiligungsmanagement mbH as part of a succession arrangement. Under SHS ownership since 2016 medigroba more than doubled revenue and tripled EBITDA and currently employs about 120 people; Löwenstein expects synergies and plans to continue the company's regional expansion and service offering.

SHS Invests in Develco Pharma

December 17, 2020

Pharmaceuticals

Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH is making a minority growth investment from its SHS V fund in Swiss-German specialty drug company Develco Pharma. Develco, headquartered in Pratteln, Switzerland with ~125 employees and production in Schopfheim, Germany, develops and manufactures orally administered prolonged-release medicines and will use the investment to broaden its pipeline and expand capabilities.